Publications by authors named "Roger Abrahams"

Claim this Profile
E
Effects of baseline symptom burden on treatment response in COPD.
Fernando J Martinez, Roger A Abrahams, Gary T Ferguson, Leif Bjermer, Lars Grönke

Int J Chron Obstruct Pulmon Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
Dave Singh, Gary T Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Roger Abrahams

Respir Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author correction. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
Roland Buhl, François Maltais, Roger Abrahams, Leif Bjermer, Eric Derom

Eur Respir J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.
Gary T Ferguson, Matjaž Fležar, Stephanie Korn, Lawrence Korducki, Lars Grönke, Roger Abrahams

Adv Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
Roland Buhl, François Maltais, Roger Abrahams, Leif Bjermer, Eric Derom

Eur Respir J· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.
Richard ZuWallack, Lisa Allen, Gemzel Hernandez, Naitee Ting, Roger Abrahams

Int J Chron Obstruct Pulmon Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.
Roger Abrahams, Petra Moroni-Zentgraf, Joe Ramsdell, Hendrik Schmidt, Elizabeth Joseph

Respir Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis